HKMPY (Hikma Pharmaceuticals) Other Long Term Assets : $388 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Other Long Term Assets?

Hikma Pharmaceuticals's other long-term assets for the quarter that ended in Dec. 2024 was $388 Mil.

Hikma Pharmaceuticals's quarterly other long-term assets declined from Dec. 2023 ($339 Mil) to Jun. 2024 ($331 Mil) but then increased from Jun. 2024 ($331 Mil) to Dec. 2024 ($388 Mil).

Hikma Pharmaceuticals's annual other long-term assets increased from Dec. 2022 ($267 Mil) to Dec. 2023 ($339 Mil) and increased from Dec. 2023 ($339 Mil) to Dec. 2024 ($388 Mil).

Hikma Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Hikma Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Other Long Term Assets Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

269.00

240.00

267.00

339.00

388.00

Hikma Pharmaceuticals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															267.00	272.00	339.00	331.00	388.00

Hikma Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Hikma Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (OTCPK:HKMPY) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

HKMPF:USA HIKl:UK HIK:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.